◆ 会议时间：2022年11月16日至20日
◆ 会议地点：美国 坦帕

◆ 会议简介：

2022年第27届美国神经肿瘤学会(SNO)年会将于2022年11月16日至20日在美国佛罗里达州坦帕举行。SNO年会是世界上最大的神经肿瘤学会议，预计有来自40多个国家的2600多名研究人员和临床科学家及其他相关专业人士与会。SNO年会议题将涵盖所有神经肿瘤学学科、专业和兴趣，将是分享知识和获得对未来神经肿瘤学研究和治疗见解的首要论坛。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

神经肿瘤学会（SNO）成立于1996年，是一个致力于通过研究和教育促进神经肿瘤学发展的非营利性多学科组织，SNO现拥有超过2000名成员，会员来自多个学科宣领域，包括流行病学、肿瘤学、神经肿瘤科、神经外科、病理、儿科、心理学、放射学、放射肿瘤学和基础科学等。二十多年来，SNO不断地成长发展，已经成为北美地区重点关注儿童和成人中枢神经系统肿瘤的临床医生、基础科学家、护士和其他卫生保健专业人员的主要组织。

摘要征集-Call for Abstracts：

点击这里提交您的摘要

Important Information

• General Abstract Deadline is Wednesday, June 1, 2022, 11:59pm EDT. (This deadline will NOT be extended).
• Late Breaking Abstract Deadline: Friday, September 2, 2022, 5:00pm EDT.
  Abstracts submitted to this category that do not fit the description criteria, will be withdrawn. For information and special guidelines on Late-Breaking Abstracts, click here.
  *Please use the web browser Google Chrome when submitting an abstract.
• Embargo Details:
• The embargo for abstracts published in the 2022 abstract supplement to SNO official journal Neuro-Oncology will lift on Friday, November 11, 2022.
• All accepted abstracts will be published and made available at: https://academic.oup.com/neuro-oncology/supplements.
• Presentation Recording Onsite:
• SNO will record all "live" slide presentations (with accompanying audio and video) during the meeting.
• Select presentations will be featured on the SNO Education Site and will be made available for online viewing.
• Traditional Poster Presentations:
• An in-person poster session will take place at the Annual Meeting. More details will be sent to the accepted poster presenters.
• Electronic Poster Presentations:
• Files will be captured electronically (in PDF) prior to the meeting and available on the mobile meeting app, website and onsite.
• Presenters will be given full credit for their presentations. For the purpose of Neuro-Oncology, Neuro-Oncology Practice, and other scholarly journals, presentation in either of these forums is not considered "prior publication."
• Registration Requirements: If your abstract is accepted for presentation at the 2022 SNO Annual Meeting, the presenting author is required to register for the meeting by the presenter registration deadline. If the presenting author does not register for the SNO Annual Meeting by this deadline, their abstract could be withdrawn from the program and will not be published in the Neuro-Oncology abstract supplement. Additional registration details will be provided in the acceptance email.
• Abstract submitters and attendees should not anticipate an option for remote participation.

• Abstract Title:
• Should be sentence case (i.e., only the first letter of the title should be capitalized)
• Should be plain text (No html)
• Word Limit: 75 words/ 200 characters
• Abstract Body:
• Word Limit: 300 words
• Figures and tables are not allowed
• Should be in a single paragraph
• If subheaders are used, they should be within that single paragraph in all-caps, not bolded (e.g., METHODS:)
• If you use the greater than/equal to symbol, you MUST put a space before entering the number.
• Abstracts should be data-driven and must include this information in the body of the abstract.
• Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. SNO neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors.
• Authors:
• There can only be 1 presenting author per submission.
  • In the the case that a presenter is unable to present, we will allow a co-author to present in their place, but we will be unable to make any edits to the printed journal.
  • The presenter must contact the SNO team immeidatedly to let us know of said change. 
• There is a maximum of 50 authors per abstract submission.
• Enter the names of authors in the order in which you wish them to appear in the printed text.
• Presenting Authors will need to complete the Presenting Author Task.
• For information and special guidelines on Late-Breaking Abstracts, click here.
• General Guidelines: 
  • Please make sure your abstract contains only generic drugs names. Abstracts with trade names in the title or body could be precluded from presentation.
  • Please be sure to carefully check your submission for content errors. SNO neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors. Errors made on your submitted abstract are likely to appear in print.
  • Please be sure to verify the presenters email address. All communication regarding the abstract will be sent to the presenting author’s email address that was entered at the time of submission.
  • If a Conflict of Interest Disclosure is required, you will be contacted directly by a SNO team member.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。